Alto Neuroscience logo

Alto Neuroscience Share Price Today

(NASDAQ: ANRO)

Alto Neuroscience share price is $3.38 & ₹293.96 as on 6 Mar 2025, 2.30 'hrs' IST

$3.38

0.27

(8.68%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Alto Neuroscience share price in Dollar and Rupees. Guide to invest in Alto Neuroscience stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Alto Neuroscience, along with analyst recommendations, forecasts, and comprehensive financials.

Alto Neuroscience share price movements

  • Today's Low: $3.23
    Today's High: $3.56

    Day's Volatility :9.14%

  • 52 Weeks Low: $2.67
    52 Weeks High: $18.35

    52 Weeks Volatility :85.45%

Alto Neuroscience (ANRO) Returns

PeriodAlto Neuroscience, Inc.Index (Russel 2000)
3 Months
-20.26%
0.0%
6 Months
-75.55%
0.0%
1 Year
-79.0%
0.0%
3 Years
-84.98%
-11.6%

Alto Neuroscience (ANRO) Key Statistics

in dollars & INR

Previous Close
$3.11
Open
$3.2
Today's High
$3.555
Today's Low
$3.23
Market Capitalization
$84.7M
Today's Volume
$95.0K
52 Week High
$18.3499
52 Week Low
$2.67
Revenue TTM
$0.0
EBITDA
$-62.9M
Earnings Per Share (EPS)
$-2.38
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-56.72%

How to invest in Alto Neuroscience Stock (ANRO) from India?

It is very easy for Indian residents to invest directly in Alto Neuroscience from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Alto Neuroscience stock in both Indian Rupees (INR) and US Dollars (USD). Search for Alto Neuroscience or ANRO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Alto Neuroscience or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Alto Neuroscience shares which would translate to 0.257 fractional shares of Alto Neuroscience as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Alto Neuroscience, in just a few clicks!

Returns in Alto Neuroscience (ANRO) for Indian investors in Rupees

The Alto Neuroscience stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Alto Neuroscience investment value today

Current value as on today

₹27,785

Returns

₹72,215

(-72.21%)

Returns from Alto Neuroscience Stock

₹77,178 (-77.18%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Alto Neuroscience (ANRO)

400%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Alto Neuroscience Stock from India on INDmoney has increased by 400% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Alto Neuroscience

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Alto Neuroscience(by analysts ranked 0 to 5 stars)

Analyst Forecast on Alto Neuroscience Stock (ANRO)

What analysts predicted

Upside of 276.43%

Target:

$12.72

Current:

$3.38

Insights on Alto Neuroscience Stock (Ticker Symbol: ANRO)

  • Price Movement

    In the last 7 days, ANRO stock has moved up by 5.8%
  • ANRO vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 142.9%

Alto Neuroscience Technicals Summary

Sell

Neutral

Buy

Alto Neuroscience is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Alto Neuroscience (ANRO) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Alto Neuroscience, Inc. logo
-25.6%
-75.55%
-79.0%
-84.98%
-84.98%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Alto Neuroscience, Inc. logo
NA
NA
NA
0.0
-0.57
-0.32
NA
6.12
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Alto Neuroscience, Inc. logo
Buy
$84.7M
-84.98%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Alto Neuroscience

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. Its product pipeline comprising ALTO-100, which is in phase 2b clinical trial for the treatment of patients with major depressive disorder (MDD); and which is in phase 2a clinical trial for the treatment of post-traumatic stress disorder. The company develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties which is in phase 2b clinical trial to treat patients with MDD; ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor which is in phase 1 clinical trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist which is in phase 1 clinical trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor which is in phase 1 clinical trial for the treatment of MDD. In addition, it develops novel pharmacodynamically synergistic combination and biomarker platform that collects patient-specific data to identify biomarker-characterized patient. The company was incorporated in 2019 and is headquartered in Los Altos, California.
Organization
Alto Neuroscience
Employees
88
CEO
Dr. Amit Etkin M.D., Ph.D.
Industry
Miscellaneous

Management People of Alto Neuroscience

NameTitle
Dr. Amit Etkin M.D., Ph.D.
Founder, Chairman of the Board, CEO & President
Mr. Nicholas C. Smith
CFO & Secretary
Mr. Adam Savitz M.D., Ph.D.
Chief Medical Officer
Mr. Dan Segal B.Sc. (Hons), BCom, CA, MSc
Co-Founder & Strategic Advisor
Mr. Michael C. Hanley M.B.A.
Chief Operating Officer
Ms. Erin R. McQuade J.D.
General Counsel & Chief Administrative Officer
Ms. Jessica Powell
Chief Development Officer

Important FAQs about investing in ANRO Stock from India :

What is Alto Neuroscience share price today?

Alto Neuroscience share price today stands at $3.38, Open: $3.20 ; Previous Close: $3.11 ; High: $3.56 ; Low: $3.23 ; 52 Week High: $18.35 ; 52 Week Low: $2.67.

The stock opens at $3.20, after a previous close of $3.11. The stock reached a daily high of $3.56 and a low of $3.23, with a 52-week high of $18.35 and a 52-week low of $2.67.

Can Indians buy Alto Neuroscience shares?

Yes, Indians can invest in the Alto Neuroscience (ANRO) from India.

With INDmoney, you can buy Alto Neuroscience at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Alto Neuroscience at zero transaction cost.

How can I buy Alto Neuroscience shares from India?

It is very easy to buy Alto Neuroscience from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Alto Neuroscience (ANRO) be purchased?

Yes, you can buy fractional shares of Alto Neuroscience with INDmoney app.

What are the documents required to start investing in Alto Neuroscience stocks?

To start investing in Alto Neuroscience, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Alto Neuroscience Stock (ANRO)?

Today’s highest price of Alto Neuroscience (ANRO) is $3.56.

Today’s lowest price of Alto Neuroscience (ANRO) is $3.23.

What is today's market capitalisation of Alto Neuroscience?

Today's market capitalisation of Alto Neuroscience ANRO is 84.7M

What is the 52 Week High and Low Range of Alto Neuroscience Stock (ANRO)?

  • 52 Week High

    $18.35

  • 52 Week Low

    $2.67

What are the historical returns of Alto Neuroscience (ANRO)?

  • 1 Month Returns

    -25.6%

  • 3 Months Returns

    -75.55%

  • 1 Year Returns

    -79%

  • 5 Years Returns

    -84.98%

Who is the Chief Executive Officer (CEO) of Alto Neuroscience ?

Dr. Amit Etkin M.D., Ph.D. is the current Chief Executive Officer (CEO) of Alto Neuroscience.